Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Foghorn Therapeutics Inc (NQ: FHTX ) 6.250 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Foghorn Therapeutics Inc < Previous 1 2 3 Next > FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Misses Revenue for Q1 2024 May 06, 2024 FHTX stock results show that Foghorn Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Beats Revenue for Q4 2023 March 07, 2024 FHTX stock results show that Foghorn Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace Foghorn Therapeutics: Q4 Earnings Insights March 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session February 08, 2024 Via Benzinga Why Foghorn Therapeutics (FHTX) Stock Is Exploding Higher February 08, 2024 Foghorn Therapeutics shares are trading higher by 44.8% Thursday. The company announced that Eli Lilly has chosen FHD-909 for clinical development. Via Benzinga What 5 Analyst Ratings Have To Say About Foghorn Therapeutics August 07, 2023 Via Benzinga Analyst Ratings for Foghorn Therapeutics June 28, 2023 Via Benzinga What 6 Analyst Ratings Have To Say About Foghorn Therapeutics June 08, 2023 Via Benzinga Analyst Expectations for Foghorn Therapeutics's Future April 25, 2023 Via Benzinga Expert Ratings for Foghorn Therapeutics March 28, 2023 Via Benzinga Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 30, 2023 Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top... Via Benzinga Schrödinger To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday June 29, 2023 Keybanc boosted the price target for Micron Technology, Inc. (NASDAQ: MU) from $70 to $80. Keybanc analyst John Vinh maintained an Overweight rating. Micron shares rose 3.9% to $69.70 in pre-market... Via Benzinga Foghorn Therapeutics Shifts Focus from Development Of Cancer Hopeful with Eye Cancer June 28, 2023 Foghorn Therapeutics Inc (NASDAQ: FHTX) announced the data from the Phase 1 dose escalation safety study of FHD-286 in Via Benzinga Foghorn Therapeutics Earnings Perspective: Return On Capital Employed March 15, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Thursday October 20, 2022 Thursday saw 177 companies set new 52-week lows. Via Benzinga Crude Oil Up 1.5%; Philips Shares Jump After Q1 Results April 24, 2023 U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 40 points on Monday. The Dow traded up 0.05% to 33,827.42 while the NASDAQ fell 0.33% to 12,032.16.... Via Benzinga Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 24, 2023 Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment. Via Benzinga US Stocks Turn Lower; Nasdaq Dips 100 Points April 24, 2023 U.S. stocks turned lower midway through trading, with the Nasdaq Composite dropping around 100 points on Monday. The Dow traded down 0.19% to 33,744.92 while the NASDAQ fell 0.84% to 11,971. The S&P... Via Benzinga More Trouble For Foghorn Therapeutics: After Blood Cancer Trial, FDA Puts Another Cancer Trial On Clinical Hold April 24, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session April 24, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023 March 28, 2023 Via Benzinga Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week February 16, 2023 Concerns about a tough financing environment weighed on clinical-stage biotech stocks this week. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 January 05, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Wednesday November 30, 2022 During Wednesday's session, 107 stocks hit new 52-week lows. Via Benzinga Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session September 30, 2022 Gainers Via Benzinga Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session September 27, 2022 Gainers Via Benzinga Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday September 28, 2022 Gainers Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022 August 24, 2022 Via Benzinga Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday September 19, 2022 Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday. Via Benzinga Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday August 24, 2022 Gainers Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.